A. Zaanan, E. Samalin, C. Louvet, C. Montérymard, F. Khemissa, et al.. 773TiPPRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma.
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain.
⟨10.1093/annonc/mdx369.155⟩.
⟨hal-01632489⟩